13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0001104659-24-061168
Total Value
$89.7M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KORRO BIO INC | KRRO | 368,085 | $33.1M | 36.93% |
| 2 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $27.3M | 30.41% |
| 3 | TOURMALINE BIO INC | 89157D105 | 741,691 | $17.0M | 18.94% |
| 4 | HILLEVAX INC | 43157M102 | 558,923 | $9.3M | 10.36% |
| 5 | VENTYX BIOSCIENCES INC | 92332V107 | 412,225 | $2.3M | 2.53% |
| 6 | KEZAR LIFE SCIENCES INC | KZR | 828,711 | $747,166 | 0.83% |